FDA Drug Shortage Database
Hydroxocobalamin (Cyanokit) shortage
The FDA Drug Shortage Database lists 2 of 2 hydroxocobalamin presentations as limited or unavailable (updated October 1, 2026); the first entry was posted on November 4, 2024.
- Generic listed
- In shortage
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 5g/250ml injection | 1 | 0 | 0 |
| 1000mcg/ml injection | 1 | 0 | 0 |
Which presentations are listed?
Limited or unavailable now (2)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11) | BTG International Inc. | Current posted November 4, 2024, updated October 1, 2026 | Limited Availability; Other |
| Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30) | Teva Pharmaceuticals USA, Inc. | Current posted November 4, 2024, updated October 1, 2026 | Unavailable; Other |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
What next?
- Every shortage now
- medicines by presentations in shortage